10/18/2024

Dronabinol Capsules

Products Affected - Description

- Dronabinol oral capsule, Major, 2.5 mg, unit-dose blister pack, 100 count, NDC 00904-7144-61 - discontinued
- Dronabinol oral capsule, Major, 5 mg, unit-dose blister pack, 30 count, NDC 00904-7145-04 - discontinued
- Dronabinol oral capsule, Rhodes, 10 mg, bottle, 60 count, NDC 42858-0869-06
- Dronabinol oral capsule, Rhodes, 2.5 mg, bottle, 60 count, NDC 42858-0867-06
- Dronabinol oral capsule, Rhodes, 5 mg, bottle, 60 count, NDC 42858-0868-06

Reason for the Shortage

- Ascend has dronabinol capsules available.
- Major discontinued dronabinol capsules in early-2024.
- Rhodes has dronabinol capsules on shortage due to manufacturing delays.

Available Products

- Dronabinol oral capsule, Ascend, 10 mg, bottle, 60 count, NDC 67877-0755-60
- Dronabinol oral capsule, Ascend, 2.5 mg, bottle, 60 count, NDC 67877-0753-60
- Dronabinol oral capsule, Ascend, 5 mg, bottle, 60 count, NDC 67877-0754-60

Estimated Resupply Dates

- Rhodes has dronabinol capsules on long-term back order and the company cannot estimate a release date.

Updated

Updated October 18, 2024 by Leslie Jensen, PharmD, Drug Information Specialist. Created December 6, 2023 by Leslie Jensen, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.